Exact Sciences
Presence
Exact Sciences is one of the...
Exact Sciences is a company listed under the stock ticker EXAS (US).
Executives
View the org chart displaying its 40 main executives
Most searched biographies at Exact Sciences
- Kevin Conroy, Chairman and Chief Executive Officer, Director
- Pierre Jacquet, Director
- Daniel Levangie, Director
Popular executive movements at Exact Sciences
- Aaron Bloomer will join the company as Chief Financial Officer on May 15, 2024 (posted on April 16 2024).
- Jeff Elliott, who is Executive Vice President, Chief Financial Officer and Chief Operating Officer will soon leave the company (posted on January 9 2024).
- Timothy Scannell has joined the company as Director (posted on November 3 2023).
Create your alert
to follow the executive moves at Exact Sciences.
Biotechnology
Exact Sciences has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Exact Sciences
- Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
- Exact Sciences Schedules First Quarter 2024 Earnings Call
- Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
- Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
- Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
- Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
- Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
- Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
- Exact Sciences Announces Fourth Quarter 2023 Results
- The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
- View more press releases Close
Social media about Exact Sciences
- Exact Sciences on Wikipedia, Google News & Yahoo Finance
- Exact Sciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Kevin Conroy 
Call Exact Sciences at +1 608...
